-
1
-
-
54149084585
-
Multiple sclerosis
-
Compston, A.; Coles, A. Multiple sclerosis. Lancet 2008, 372, 1502-1517.
-
(2008)
Lancet
, vol.372
, pp. 1502-1517
-
-
Compston, A.1
Coles, A.2
-
2
-
-
84940453103
-
Immunopathology of multiple sclerosis
-
Dendrou, C.A.; Fugger, L.; Friese, M.A. Immunopathology of multiple sclerosis. Nat. Rev. Immunol. 2015, 15, 545-558.
-
(2015)
Nat. Rev. Immunol
, vol.15
, pp. 545-558
-
-
Dendrou, C.A.1
Fugger, L.2
Friese, M.A.3
-
3
-
-
84930930111
-
Pharmacological approaches to delaying disability progression in patients with multiple sclerosis
-
Wiendl, H.; Meuth, S.G. Pharmacological approaches to delaying disability progression in patients with multiple sclerosis. Drugs 2015, 75, 947-977.
-
(2015)
Drugs
, vol.75
, pp. 947-977
-
-
Wiendl, H.1
Meuth, S.G.2
-
5
-
-
84991772094
-
Multiple sclerosis: Experimental models and reality
-
Lassmann, H.; Bradl, M. Multiple sclerosis: Experimental models and reality. Acta Neuropathol. 2017, 133, 223-244.
-
(2017)
Acta Neuropathol
, vol.133
, pp. 223-244
-
-
Lassmann, H.1
Bradl, M.2
-
6
-
-
0036219003
-
T cell response in experimental autoimmune encephalomyelitis (EAE): Role of self and cross-reactive antigens in shaping, tuning, and regulating the autopathogenic T cell repertoire
-
Kuchroo, V.K.; Anderson, A.C.; Waldner, H.; Munder, M.; Bettelli, E.; Nicholson, L.B. T cell response in experimental autoimmune encephalomyelitis (EAE): Role of self and cross-reactive antigens in shaping, tuning, and regulating the autopathogenic T cell repertoire. Annu. Rev. Immunol. 2002, 20, 101-123.
-
(2002)
Annu. Rev. Immunol
, vol.20
, pp. 101-123
-
-
Kuchroo, V.K.1
Anderson, A.C.2
Waldner, H.3
Munder, M.4
Bettelli, E.5
Nicholson, L.B.6
-
7
-
-
81755184012
-
Cytokines and effector T cell subsets causing autoimmune CNS disease
-
Petermann, F.; Korn, T. Cytokines and effector T cell subsets causing autoimmune CNS disease. FEBS Lett. 2011, 585, 3747-3757.
-
(2011)
FEBS Lett
, vol.585
, pp. 3747-3757
-
-
Petermann, F.1
Korn, T.2
-
8
-
-
84933512276
-
T cell mediated pathogenesis in EAE: Molecular mechanisms
-
Kurschus, F.C. T cell mediated pathogenesis in EAE: Molecular mechanisms. Biomed. J. 2015, 38, 183-193.
-
(2015)
Biomed. J
, vol.38
, pp. 183-193
-
-
Kurschus, F.C.1
-
9
-
-
84864124859
-
IL-12 family cytokines: Immunological playmakers
-
Vignali, D.A.; Kuchroo, V.K. IL-12 family cytokines: Immunological playmakers. Nat. Immunol. 2012, 13, 722-728.
-
(2012)
Nat. Immunol
, vol.13
, pp. 722-728
-
-
Vignali, D.A.1
Kuchroo, V.K.2
-
10
-
-
35848951169
-
Autoaggressive effector T cells in the course of experimental autoimmune encephalomyelitis visualized in the light of two-photon microscopy
-
Flugel, A.; Odoardi, F.; Nosov, M.; Kawakami, N. Autoaggressive effector T cells in the course of experimental autoimmune encephalomyelitis visualized in the light of two-photon microscopy. J. Neuroimmunol. 2007, 191, 86-97.
-
(2007)
J. Neuroimmunol
, vol.191
, pp. 86-97
-
-
Flugel, A.1
Odoardi, F.2
Nosov, M.3
Kawakami, N.4
-
11
-
-
84896902938
-
Chemokines and chemokine receptors: Positioning cells for host defense and immunity
-
Griffith, J.W.; Sokol, C.L.; Luster, A.D. Chemokines and chemokine receptors: Positioning cells for host defense and immunity. Annu. Rev. Immunol. 2014, 32, 659-702.
-
(2014)
Annu. Rev. Immunol
, vol.32
, pp. 659-702
-
-
Griffith, J.W.1
Sokol, C.L.2
Luster, A.D.3
-
12
-
-
84861426163
-
The chemokine superfamily revisited
-
Zlotnik, A.; Yoshie, O. The chemokine superfamily revisited. Immunity 2012, 36, 705-716.
-
(2012)
Immunity
, vol.36
, pp. 705-716
-
-
Zlotnik, A.1
Yoshie, O.2
-
13
-
-
34547281274
-
Chemokines and chemokine receptors: Multipurpose players in neuroinflammation
-
Ransohoff, R.M.; Liu, L.; Cardona, A.E. Chemokines and chemokine receptors: Multipurpose players in neuroinflammation. Int. Rev. Neurobiol. 2007, 82, 187-204.
-
(2007)
Int. Rev. Neurobiol
, vol.82
, pp. 187-204
-
-
Ransohoff, R.M.1
Liu, L.2
Cardona, A.E.3
-
14
-
-
50049123401
-
Chemokines and leukocyte traffic
-
Sallusto, F.; Baggiolini, M. Chemokines and leukocyte traffic. Nat. Immunol. 2008, 9, 949-952.
-
(2008)
Nat. Immunol
, vol.9
, pp. 949-952
-
-
Sallusto, F.1
Baggiolini, M.2
-
15
-
-
0034083091
-
The role of chemokine receptors in primary, effector, and memory immune responses
-
Sallusto, F.; Mackay, C.R.; Lanzavecchia, A. The role of chemokine receptors in primary, effector, and memory immune responses. Annu. Rev. Immunol. 2000, 18, 593-620.
-
(2000)
Annu. Rev. Immunol
, vol.18
, pp. 593-620
-
-
Sallusto, F.1
Mackay, C.R.2
Lanzavecchia, A.3
-
16
-
-
34248339649
-
Chemokines and chemokine receptors in the brain: Implication in neuroendocrine regulation
-
Callewaere, C.; Banisadr, G.; Rostene, W.; Parsadaniantz, S.M. Chemokines and chemokine receptors in the brain: Implication in neuroendocrine regulation. J. Mol. Endocrinol. 2007, 38, 355-363.
-
(2007)
J. Mol. Endocrinol
, vol.38
, pp. 355-363
-
-
Callewaere, C.1
Banisadr, G.2
Rostene, W.3
Parsadaniantz, S.M.4
-
17
-
-
70449525704
-
Chemokines and chemokine receptors: Standing at the crossroads of immunobiology and neurobiology
-
Ransohoff, R.M. Chemokines and chemokine receptors: Standing at the crossroads of immunobiology and neurobiology. Immunity 2009, 31, 711-721.
-
(2009)
Immunity
, vol.31
, pp. 711-721
-
-
Ransohoff, R.M.1
-
18
-
-
35549006675
-
Chemokines: A new class of neuromodulator?
-
Rostene, W.; Kitabgi, P.; Parsadaniantz, S.M. Chemokines: A new class of neuromodulator? Nat. Rev. Neurosci. 2007, 8, 895-903.
-
(2007)
Nat. Rev. Neurosci
, vol.8
, pp. 895-903
-
-
Rostene, W.1
Kitabgi, P.2
Parsadaniantz, S.M.3
-
19
-
-
84941804524
-
Fractalkine in the nervous system: Neuroprotective or neurotoxic molecule?
-
Lauro, C.; Catalano, M.; Trettel, F.; Limatola, C. Fractalkine in the nervous system: Neuroprotective or neurotoxic molecule? Ann. N. Y. Acad. Sci. 2015, 1351, 141-148.
-
(2015)
Ann. N. Y. Acad. Sci
, vol.1351
, pp. 141-148
-
-
Lauro, C.1
Catalano, M.2
Trettel, F.3
Limatola, C.4
-
20
-
-
84977519286
-
Atypical Chemokine Receptors and Their Roles in the Resolution of the Inflammatory Response
-
Bonecchi, R.; Graham, G.J. Atypical Chemokine Receptors and Their Roles in the Resolution of the Inflammatory Response. Front. Immunol. 2016, 7, 224.
-
(2016)
Front. Immunol
, vol.7
, pp. 224
-
-
Bonecchi, R.1
Graham, G.J.2
-
21
-
-
79952105330
-
Chemokine oligomerization and interactions with receptors and glycosaminoglycans: The role of structural dynamics in function
-
Salanga, C.L.; Handel, T.M. Chemokine oligomerization and interactions with receptors and glycosaminoglycans: The role of structural dynamics in function. Exp. Cell Res. 2011, 317, 590-601.
-
(2011)
Exp. Cell Res
, vol.317
, pp. 590-601
-
-
Salanga, C.L.1
Handel, T.M.2
-
22
-
-
54849415924
-
Fluorescence resonance energy transfer imaging reveals that chemokine-binding modulates heterodimers of CXCR4 and CCR5 receptors
-
Isik, N.; Hereld, D.; Jin, T. Fluorescence resonance energy transfer imaging reveals that chemokine-binding modulates heterodimers of CXCR4 and CCR5 receptors. PLoS ONE 2008, 3, e3424.
-
(2008)
PLoS ONE
, vol.3
-
-
Isik, N.1
Hereld, D.2
Jin, T.3
-
23
-
-
0035082676
-
CCR5, CXCR4, and CD4 are clustered and closely apposed on microvilli of human macrophages and T cells
-
Singer, I.I.; Scott, S.; Kawka, D.W.; Chin, J.; Daugherty, B.L.; DeMartino, J.A.; DiSalvo, J.; Gould, S.L.; Lineberger, J.E.; Malkowitz, L.; et al. CCR5, CXCR4, and CD4 are clustered and closely apposed on microvilli of human macrophages and T cells. J. Virol. 2001, 75, 3779-3790.
-
(2001)
J. Virol
, vol.75
, pp. 3779-3790
-
-
Singer, I.I.1
Scott, S.2
Kawka, D.W.3
Chin, J.4
Daugherty, B.L.5
DeMartino, J.A.6
DiSalvo, J.7
Gould, S.L.8
Lineberger, J.E.9
Malkowitz, L.10
-
24
-
-
85012912282
-
Differential structural remodelling of heparan sulfate by chemokines: The role of chemokine oligomerization
-
Dyer, D.P.; Migliorini, E.; Salanga, C.L.; Thakar, D.; Handel, T.M.; Richter, R.P. Differential structural remodelling of heparan sulfate by chemokines: The role of chemokine oligomerization. Open Biol. 2017, 7.
-
(2017)
Open Biol
, vol.7
-
-
Dyer, D.P.1
Migliorini, E.2
Salanga, C.L.3
Thakar, D.4
Handel, T.M.5
Richter, R.P.6
-
25
-
-
84959429965
-
The dependence of chemokine-glycosaminoglycan interactions on chemokine oligomerization
-
Dyer, D.P.; Salanga, C.L.; Volkman, B.F.; Kawamura, T.; Handel, T.M. The dependence of chemokine-glycosaminoglycan interactions on chemokine oligomerization. Glycobiology 2016, 26, 312-326.
-
(2016)
Glycobiology
, vol.26
, pp. 312-326
-
-
Dyer, D.P.1
Salanga, C.L.2
Volkman, B.F.3
Kawamura, T.4
Handel, T.M.5
-
26
-
-
0029102101
-
Molecular cloning and functional expression of a novel CC chemokine receptor cDNA from a human basophilic cell line
-
Power, C.A.; Meyer, A.; Nemeth, K.; Bacon, K.B.; Hoogewerf, A.J.; Proudfoot, A.E.; Wells, T.N. Molecular cloning and functional expression of a novel CC chemokine receptor cDNA from a human basophilic cell line. J. Biol. Chem. 1995, 270, 19495-19500.
-
(1995)
J. Biol. Chem
, vol.270
, pp. 19495-19500
-
-
Power, C.A.1
Meyer, A.2
Nemeth, K.3
Bacon, K.B.4
Hoogewerf, A.J.5
Proudfoot, A.E.6
Wells, T.N.7
-
27
-
-
0030021091
-
Molecular cloning of murine CC CKR-4 and high affinity binding of chemokines to murine and human CC CKR-4
-
Hoogewerf, A.; Black, D.; Proudfoot, A.E.; Wells, T.N.; Power, C.A. Molecular cloning of murine CC CKR-4 and high affinity binding of chemokines to murine and human CC CKR-4. Biochem. Biophys. Res. Commun. 1996, 218, 337-343.
-
(1996)
Biochem. Biophys. Res. Commun
, vol.218
, pp. 337-343
-
-
Hoogewerf, A.1
Black, D.2
Proudfoot, A.E.3
Wells, T.N.4
Power, C.A.5
-
28
-
-
84922475661
-
CCR4 and its ligands: From bench to bedside
-
Yoshie, O.; Matsushima, K. CCR4 and its ligands: From bench to bedside. Int. Immunol. 2015, 27, 11-20.
-
(2015)
Int. Immunol
, vol.27
, pp. 11-20
-
-
Yoshie, O.1
Matsushima, K.2
-
29
-
-
0032533795
-
Selective up-regulation of chemokine receptors CCR4 and CCR8 upon activation of polarized human type 2 Th cells
-
D’Ambrosio, D.; Iellem, A.; Bonecchi, R.; Mazzeo, D.; Sozzani, S.; Mantovani, A.; Sinigaglia, F. Selective up-regulation of chemokine receptors CCR4 and CCR8 upon activation of polarized human type 2 Th cells. J. Immunol. 1998, 161, 5111-5115.
-
(1998)
J. Immunol
, vol.161
, pp. 5111-5115
-
-
D’Ambrosio, D.1
Iellem, A.2
Bonecchi, R.3
Mazzeo, D.4
Sozzani, S.5
Mantovani, A.6
Sinigaglia, F.7
-
30
-
-
0033140106
-
The role of chemokines and chemokine receptors in T cell priming and Th1/Th2-mediated responses
-
Sallusto, F. The role of chemokines and chemokine receptors in T cell priming and Th1/Th2-mediated responses. Haematologica 1999, 84, 28-31.
-
(1999)
Haematologica
, vol.84
, pp. 28-31
-
-
Sallusto, F.1
-
31
-
-
34249079176
-
Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells
-
Acosta-Rodriguez, E.V.; Rivino, L.; Geginat, J.; Jarrossay, D.; Gattorno, M.; Lanzavecchia, A.; Sallusto, F.; Napolitani, G. Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells. Nat. Immunol. 2007, 8, 639-646.
-
(2007)
Nat. Immunol
, vol.8
, pp. 639-646
-
-
Acosta-Rodriguez, E.V.1
Rivino, L.2
Geginat, J.3
Jarrossay, D.4
Gattorno, M.5
Lanzavecchia, A.6
Sallusto, F.7
Napolitani, G.8
-
32
-
-
84866289004
-
Reply to Othy et al.: Dendritic cell-specific expression of CCR4 is required for development of EAE
-
Alferink, J.; Poppensieker, K.; Otte, D.-M.; Klotz, L.; Scheu, S.; Maier, W.; Zimmer, A. Reply to Othy et al.: Dendritic cell-specific expression of CCR4 is required for development of EAE. Proc. Natl. Acad. Sci. USA 2012, 109, E2414.
-
(2012)
Proc. Natl. Acad. Sci. USA
, vol.109
, pp. 2414
-
-
Alferink, J.1
Poppensieker, K.2
Otte, D.-M.3
Klotz, L.4
Scheu, S.5
Maier, W.6
Zimmer, A.7
-
33
-
-
40449111457
-
Human Th17 cells share major trafficking receptors with both polarized effector T cells and FOXP3+ regulatory T cells
-
Lim, H.W.; Lee, J.; Hillsamer, P.; Kim, C.H. Human Th17 cells share major trafficking receptors with both polarized effector T cells and FOXP3+ regulatory T cells. J. Immunol. 2008, 180, 122-129.
-
(2008)
J. Immunol
, vol.180
, pp. 122-129
-
-
Lim, H.W.1
Lee, J.2
Hillsamer, P.3
Kim, C.H.4
-
34
-
-
33751569559
-
Evidence for NK cell subsets based on chemokine receptor expression
-
Berahovich, R.D.; Lai, N.L.; Wei, Z.; Lanier, L.L.; Schall, T.J. Evidence for NK cell subsets based on chemokine receptor expression. J. Immunol. 2006, 177, 7833-7840.
-
(2006)
J. Immunol
, vol.177
, pp. 7833-7840
-
-
Berahovich, R.D.1
Lai, N.L.2
Wei, Z.3
Lanier, L.L.4
Schall, T.J.5
-
35
-
-
0034657856
-
A key role for CC chemokine receptor 4 in lipopolysaccharide-induced endotoxic shock
-
Chvatchko, Y.; Hoogewerf, A.J.; Meyer, A.; Alouani, S.; Juillard, P.; Buser, R.; Conquet, F.; Proudfoot, A.E.; Wells, T.N.; Power, C.A. A key role for CC chemokine receptor 4 in lipopolysaccharide-induced endotoxic shock. J. Exp. Med. 2000, 191, 1755-1764.
-
(2000)
J. Exp. Med
, vol.191
, pp. 1755-1764
-
-
Chvatchko, Y.1
Hoogewerf, A.J.2
Meyer, A.3
Alouani, S.4
Juillard, P.5
Buser, R.6
Conquet, F.7
Proudfoot, A.E.8
Wells, T.N.9
Power, C.A.10
-
36
-
-
0036709217
-
Induction of macrophage-derived chemokine/CCL22 expression in experimental autoimmune encephalomyelitis and cultured microglia: Implications for disease regulation
-
Columba-Cabezas, S.; Serafini, B.; Ambrosini, E.; Sanchez, M.; Penna, G.; Adorini, L.; Aloisi, F. Induction of macrophage-derived chemokine/CCL22 expression in experimental autoimmune encephalomyelitis and cultured microglia: Implications for disease regulation. J. Neuroimmunol. 2002, 130, 10-21.
-
(2002)
J. Neuroimmunol
, vol.130
, pp. 10-21
-
-
Columba-Cabezas, S.1
Serafini, B.2
Ambrosini, E.3
Sanchez, M.4
Penna, G.5
Adorini, L.6
Aloisi, F.7
-
37
-
-
84857938454
-
CC chemokine receptor 4 is required for experimental autoimmune encephalomyelitis by regulating GM-CSF and IL-23 production in dendritic cells
-
Poppensieker, K.; Otte, D.M.; Schurmann, B.; Limmer, A.; Dresing, P.; Drews, E.; Schumak, B.; Klotz, L.; Raasch, J.; Mildner, A.; et al. CC chemokine receptor 4 is required for experimental autoimmune encephalomyelitis by regulating GM-CSF and IL-23 production in dendritic cells. Proc. Natl. Acad. Sci. USA 2012, 109, 3897-3902.
-
(2012)
Proc. Natl. Acad. Sci. USA
, vol.109
, pp. 3897-3902
-
-
Poppensieker, K.1
Otte, D.M.2
Schurmann, B.3
Limmer, A.4
Dresing, P.5
Drews, E.6
Schumak, B.7
Klotz, L.8
Raasch, J.9
Mildner, A.10
-
38
-
-
0036247211
-
Cytokines and chemoattractants in allergic inflammation
-
Romagnani, S. Cytokines and chemoattractants in allergic inflammation. Mol. Immunol. 2002, 38, 881-885.
-
(2002)
Mol. Immunol
, vol.38
, pp. 881-885
-
-
Romagnani, S.1
-
39
-
-
79959415857
-
Chemokine receptor requirements for epidermal T-cell trafficking
-
Tubo, N.J.; McLachlan, J.B.; Campbell, J.J. Chemokine receptor requirements for epidermal T-cell trafficking. Am. J. Pathol. 2011, 178, 2496-2503.
-
(2011)
Am. J. Pathol
, vol.178
, pp. 2496-2503
-
-
Tubo, N.J.1
McLachlan, J.B.2
Campbell, J.J.3
-
40
-
-
0036672988
-
-/- mice
-
-/- mice. FASEB J. Off. Publ. Fed. Am. Soc. Exp. Biol. 2002, 16, 1313-1315.
-
(2002)
FASEB J. Off. Publ. Fed. Am. Soc. Exp. Biol
, vol.16
, pp. 1313-1315
-
-
Schuh, J.M.1
Power, C.2
Proudfoot, A.E.3
Kunkel, S.L.4
Lukacs, N.W.5
Hogaboam, C.M.6
-
41
-
-
14744305250
-
New chemokine targets for asthma therapy
-
Garcia, G.; Godot, V.; Humbert, M. New chemokine targets for asthma therapy. Curr. Allergy Asthma Rep. 2005, 5, 155-160.
-
(2005)
Curr. Allergy Asthma Rep
, vol.5
, pp. 155-160
-
-
Garcia, G.1
Godot, V.2
Humbert, M.3
-
42
-
-
33947254437
-
Cutting Edge: Chemokine receptor CCR4 is necessary for antigen-driven cutaneous accumulation of CD4 T cells under physiological conditions
-
Campbell, J.J.; O’Connell, D.J.; Wurbel, M.A. Cutting Edge: Chemokine receptor CCR4 is necessary for antigen-driven cutaneous accumulation of CD4 T cells under physiological conditions. J. Immunol. 2007, 178, 3358-3362.
-
(2007)
J. Immunol
, vol.178
, pp. 3358-3362
-
-
Campbell, J.J.1
O’Connell, D.J.2
Wurbel, M.A.3
-
43
-
-
33751568123
-
CCR4 is a key modulator of innate immune responses
-
Ness, T.L.; Ewing, J.L.; Hogaboam, C.M.; Kunkel, S.L. CCR4 is a key modulator of innate immune responses. J. Immunol. 2006, 177, 7531-7539.
-
(2006)
J. Immunol
, vol.177
, pp. 7531-7539
-
-
Ness, T.L.1
Ewing, J.L.2
Hogaboam, C.M.3
Kunkel, S.L.4
-
44
-
-
55849150528
-
Detrimental role of CC chemokine receptor 4 in murine polymicrobial sepsis
-
Traeger, T.; Kessler, W.; Assfalg, V.; Cziupka, K.; Koerner, P.; Dassow, C.; Breitbach, K.; Mikulcak, M.; Steinmetz, I.; Pfeffer, K.; et al. Detrimental role of CC chemokine receptor 4 in murine polymicrobial sepsis. Infect. Immun. 2008, 76, 5285-5293.
-
(2008)
Infect. Immun
, vol.76
, pp. 5285-5293
-
-
Traeger, T.1
Kessler, W.2
Assfalg, V.3
Cziupka, K.4
Koerner, P.5
Dassow, C.6
Breitbach, K.7
Mikulcak, M.8
Steinmetz, I.9
Pfeffer, K.10
-
45
-
-
0030987778
-
The T cell-directed CC chemokine TARC is a highly specific biological ligand for CC chemokine receptor 4
-
Imai, T.; Baba, M.; Nishimura, M.; Kakizaki, M.; Takagi, S.; Yoshie, O. The T cell-directed CC chemokine TARC is a highly specific biological ligand for CC chemokine receptor 4. J. Biol. Chem. 1997, 272, 15036-15042.
-
(1997)
J. Biol. Chem
, vol.272
, pp. 15036-15042
-
-
Imai, T.1
Baba, M.2
Nishimura, M.3
Kakizaki, M.4
Takagi, S.5
Yoshie, O.6
-
46
-
-
0342316467
-
The murine beta-chemokine TARC is expressed by subsets of dendritic cells and attracts primed CD4+ T cells
-
Lieberam, I.; Forster, I. The murine beta-chemokine TARC is expressed by subsets of dendritic cells and attracts primed CD4+ T cells. Eur. J. Immunol. 1999, 29, 2684-2694.
-
(1999)
Eur. J. Immunol
, vol.29
, pp. 2684-2694
-
-
Lieberam, I.1
Forster, I.2
-
47
-
-
0037416171
-
Compartmentalized production of CCL17 in vivo: Strong inducibility in peripheral dendritic cells contrasts selective absence from the spleen
-
Alferink, J.; Lieberam, I.; Reindl, W.; Behrens, A.; Weiss, S.; Huser, N.; Gerauer, K.; Ross, R.; Reske-Kunz, A.B.; Ahmad-Nejad, P.; et al. Compartmentalized production of CCL17 in vivo: Strong inducibility in peripheral dendritic cells contrasts selective absence from the spleen. J. Exp. Med. 2003, 197, 585-599.
-
(2003)
J. Exp. Med
, vol.197
, pp. 585-599
-
-
Alferink, J.1
Lieberam, I.2
Reindl, W.3
Behrens, A.4
Weiss, S.5
Huser, N.6
Gerauer, K.7
Ross, R.8
Reske-Kunz, A.B.9
Ahmad-Nejad, P.10
-
48
-
-
84893589101
-
Cytokine-dependent regulation of dendritic cell differentiation in the splenic microenvironment
-
Globisch, T.; Steiner, N.; Fulle, L.; Lukacs-Kornek, V.; Degrandi, D.; Dresing, P.; Alferink, J.; Lang, R.; Pfeffer, K.; Beyer, M.; et al. Cytokine-dependent regulation of dendritic cell differentiation in the splenic microenvironment. Eur. J. Immunol. 2014, 44, 500-510.
-
(2014)
Eur. J. Immunol
, vol.44
, pp. 500-510
-
-
Globisch, T.1
Steiner, N.2
Fulle, L.3
Lukacs-Kornek, V.4
Degrandi, D.5
Dresing, P.6
Alferink, J.7
Lang, R.8
Pfeffer, K.9
Beyer, M.10
-
49
-
-
84856231283
-
CCL17 promotes intestinal inflammation in mice and counteracts regulatory T cell-mediated protection from colitis
-
Heiseke, A.F.; Faul, A.C.; Lehr, H.A.; Forster, I.; Schmid, R.M.; Krug, A.B.; Reindl, W. CCL17 promotes intestinal inflammation in mice and counteracts regulatory T cell-mediated protection from colitis. Gastroenterology 2012, 142, 335-345.
-
(2012)
Gastroenterology
, vol.142
, pp. 335-345
-
-
Heiseke, A.F.1
Faul, A.C.2
Lehr, H.A.3
Forster, I.4
Schmid, R.M.5
Krug, A.B.6
Reindl, W.7
-
50
-
-
77952733308
-
Requirement of CCL17 for CCR7- and CXCR4-dependent migration of cutaneous dendritic cells
-
Stutte, S.; Quast, T.; Gerbitzki, N.; Savinko, T.; Novak, N.; Reifenberger, J.; Homey, B.; Kolanus, W.; Alenius, H.; Forster, I. Requirement of CCL17 for CCR7- and CXCR4-dependent migration of cutaneous dendritic cells. Proc. Natl. Acad. Sci. USA 2010, 107, 8736-8741.
-
(2010)
Proc. Natl. Acad. Sci. USA
, vol.107
, pp. 8736-8741
-
-
Stutte, S.1
Quast, T.2
Gerbitzki, N.3
Savinko, T.4
Novak, N.5
Reifenberger, J.6
Homey, B.7
Kolanus, W.8
Alenius, H.9
Forster, I.10
-
51
-
-
0025735629
-
The dendritic cell system and its role in immunogenicity
-
Steinman, R.M. The dendritic cell system and its role in immunogenicity. Annu. Rev. Immunol. 1991, 9, 271-296.
-
(1991)
Annu. Rev. Immunol
, vol.9
, pp. 271-296
-
-
Steinman, R.M.1
-
52
-
-
0036518287
-
Mouse and human dendritic cell subtypes
-
Shortman, K.; Liu, Y.J. Mouse and human dendritic cell subtypes. Nat. Rev. Immunol. 2002, 2, 151-161.
-
(2002)
Nat. Rev. Immunol
, vol.2
, pp. 151-161
-
-
Shortman, K.1
Liu, Y.J.2
-
53
-
-
77949830320
-
Alternative cross-priming through CCL17-CCR4-mediated attraction of CTLs toward NKT cell-licensed DCs
-
Semmling, V.; Lukacs-Kornek, V.; Thaiss, C.A.; Quast, T.; Hochheiser, K.; Panzer, U.; Rossjohn, J.; Perlmutter, P.; Cao, J.; Godfrey, D.I.; et al. Alternative cross-priming through CCL17-CCR4-mediated attraction of CTLs toward NKT cell-licensed DCs. Nat. Immunol. 2010, 11, 313-320.
-
(2010)
Nat. Immunol
, vol.11
, pp. 313-320
-
-
Semmling, V.1
Lukacs-Kornek, V.2
Thaiss, C.A.3
Quast, T.4
Hochheiser, K.5
Panzer, U.6
Rossjohn, J.7
Perlmutter, P.8
Cao, J.9
Godfrey, D.I.10
-
54
-
-
79960020852
-
CCL17-expressing dendritic cells drive atherosclerosis by restraining regulatory T cell homeostasis in mice
-
Weber, C.; Meiler, S.; Doring, Y.; Koch, M.; Drechsler, M.; Megens, R.T.; Rowinska, Z.; Bidzhekov, K.; Fecher, C.; Ribechini, E.; et al. CCL17-expressing dendritic cells drive atherosclerosis by restraining regulatory T cell homeostasis in mice. J. Clin. Investig. 2011, 121, 2898-2910.
-
(2011)
J. Clin. Investig
, vol.121
, pp. 2898-2910
-
-
Weber, C.1
Meiler, S.2
Doring, Y.3
Koch, M.4
Drechsler, M.5
Megens, R.T.6
Rowinska, Z.7
Bidzhekov, K.8
Fecher, C.9
Ribechini, E.10
-
55
-
-
0031893264
-
Macrophage-derived chemokine is a functional ligand for the CC chemokine receptor 4
-
Imai, T.; Chantry, D.; Raport, C.J.; Wood, C.L.; Nishimura, M.; Godiska, R.; Yoshie, O.; Gray, P.W. Macrophage-derived chemokine is a functional ligand for the CC chemokine receptor 4. J. Biol. Chem. 1998, 273, 1764-1768.
-
(1998)
J. Biol. Chem
, vol.273
, pp. 1764-1768
-
-
Imai, T.1
Chantry, D.2
Raport, C.J.3
Wood, C.L.4
Nishimura, M.5
Godiska, R.6
Yoshie, O.7
Gray, P.W.8
-
56
-
-
0031849219
-
Human chemokines fractalkine (SCYD1), MDC (SCYA22) and TARC (SCYA17) are clustered on chromosome 16q13
-
Nomiyama, H.; Imai, T.; Kusuda, J.; Miura, R.; Callen, D.F.; Yoshie, O. Human chemokines fractalkine (SCYD1), MDC (SCYA22) and TARC (SCYA17) are clustered on chromosome 16q13. Cytogenet. Cell Genet. 1998, 81, 10-11.
-
(1998)
Cytogenet. Cell Genet
, vol.81
, pp. 10-11
-
-
Nomiyama, H.1
Imai, T.2
Kusuda, J.3
Miura, R.4
Callen, D.F.5
Yoshie, O.6
-
57
-
-
67650485985
-
Alternative activation of macrophages: An immunologic functional perspective
-
Martinez, F.O.; Helming, L.; Gordon, S. Alternative activation of macrophages: An immunologic functional perspective. Annu. Rev. Immunol. 2009, 27, 451-483.
-
(2009)
Annu. Rev. Immunol
, vol.27
, pp. 451-483
-
-
Martinez, F.O.1
Helming, L.2
Gordon, S.3
-
58
-
-
0035500756
-
Cutting edge: CCR4 mediates antigen-primed T cell binding to activated dendritic cells
-
Wu, M.; Fang, H.; Hwang, S.T. Cutting edge: CCR4 mediates antigen-primed T cell binding to activated dendritic cells. J. Immunol. 2001, 167, 4791-4795.
-
(2001)
J. Immunol
, vol.167
, pp. 4791-4795
-
-
Wu, M.1
Fang, H.2
Hwang, S.T.3
-
59
-
-
0036032065
-
Regulation of macrophage-derived chemokine (MDC, CCL22) production
-
Yamashita, U.; Kuroda, E. Regulation of macrophage-derived chemokine (MDC, CCL22) production. Crit. Rev. Immunol. 2002, 22, 105-114.
-
(2002)
Crit. Rev. Immunol
, vol.22
, pp. 105-114
-
-
Yamashita, U.1
Kuroda, E.2
-
60
-
-
0035086113
-
Dendritic cells as a major source of macrophage-derived chemokine/CCL22 in vitro and in vivo
-
Vulcano, M.; Albanesi, C.; Stoppacciaro, A.; Bagnati, R.; D’Amico, G.; Struyf, S.; Transidico, P.; Bonecchi, R.; Del Prete, A.; Allavena, P.; et al. Dendritic cells as a major source of macrophage-derived chemokine/CCL22 in vitro and in vivo. Eur. J. Immunol. 2001, 31, 812-822.
-
(2001)
Eur. J. Immunol
, vol.31
, pp. 812-822
-
-
Vulcano, M.1
Albanesi, C.2
Stoppacciaro, A.3
Bagnati, R.4
D’Amico, G.5
Struyf, S.6
Transidico, P.7
Bonecchi, R.8
Del Prete, A.9
Allavena, P.10
-
61
-
-
0033638894
-
Macrophage-derived chemokine (MDC)
-
Mantovani, A.; Gray, P.A.; Van Damme, J.; Sozzani, S. Macrophage-derived chemokine (MDC). J. Leukoc. Biol. 2000, 68, 400-404.
-
(2000)
J. Leukoc. Biol
, vol.68
, pp. 400-404
-
-
Mantovani, A.1
Gray, P.A.2
Van Damme, J.3
Sozzani, S.4
-
62
-
-
0037381799
-
Both IL-4 and IL-13 inhibit the TNF-alpha and IFN-gamma enhanced MDC production in a human keratinocyte cell line, HaCaT cells
-
Xiao, T.; Kagami, S.; Saeki, H.; Sugaya, M.; Kakinuma, T.; Fujita, H.; Yano, S.; Mitsui, H.; Torii, H.; Komine, M.; et al. Both IL-4 and IL-13 inhibit the TNF-alpha and IFN-gamma enhanced MDC production in a human keratinocyte cell line, HaCaT cells. J. Dermatol. Sci. 2003, 31, 111-117.
-
(2003)
J. Dermatol. Sci
, vol.31
, pp. 111-117
-
-
Xiao, T.1
Kagami, S.2
Saeki, H.3
Sugaya, M.4
Kakinuma, T.5
Fujita, H.6
Yano, S.7
Mitsui, H.8
Torii, H.9
Komine, M.10
-
63
-
-
84861668636
-
Dendritic cells and alveolar macrophages mediate IL-13-induced airway inflammation and chemokine production
-
Crapster-Pregont, M.; Yeo, J.; Sanchez, R.L.; Kuperman, D.A. Dendritic cells and alveolar macrophages mediate IL-13-induced airway inflammation and chemokine production. J. Allergy Clin. Immunol. 2012, 129, 1621-1627.
-
(2012)
J. Allergy Clin. Immunol
, vol.129
, pp. 1621-1627
-
-
Crapster-Pregont, M.1
Yeo, J.2
Sanchez, R.L.3
Kuperman, D.A.4
-
64
-
-
79960983261
-
Prevention of murine autoimmune diabetes by CCL22-mediated Treg recruitment to the pancreatic islets
-
Montane, J.; Bischoff, L.; Soukhatcheva, G.; Dai, D.L.; Hardenberg, G.; Levings, M.K.; Orban, P.C.; Kieffer, T.J.; Tan, R.; Verchere, C.B. Prevention of murine autoimmune diabetes by CCL22-mediated Treg recruitment to the pancreatic islets. J. Clin. Investig. 2011, 121, 3024-3028.
-
(2011)
J. Clin. Investig
, vol.121
, pp. 3024-3028
-
-
Montane, J.1
Bischoff, L.2
Soukhatcheva, G.3
Dai, D.L.4
Hardenberg, G.5
Levings, M.K.6
Orban, P.C.7
Kieffer, T.J.8
Tan, R.9
Verchere, C.B.10
-
65
-
-
4644237613
-
Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival
-
Curiel, T.J.; Coukos, G.; Zou, L.; Alvarez, X.; Cheng, P.; Mottram, P.; Evdemon-Hogan, M.; Conejo-Garcia, J.R.; Zhang, L.; Burow, M.; et al. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat. Med. 2004, 10, 942-949.
-
(2004)
Nat. Med
, vol.10
, pp. 942-949
-
-
Curiel, T.J.1
Coukos, G.2
Zou, L.3
Alvarez, X.4
Cheng, P.5
Mottram, P.6
Evdemon-Hogan, M.7
Conejo-Garcia, J.R.8
Zhang, L.9
Burow, M.10
-
66
-
-
0032530062
-
Enhanced anti-HIV-1 activity and altered chemotactic potency of NH2-terminally processed macrophage-derived chemokine (MDC) imply an additional MDC receptor
-
Struyf, S.; Proost, P.; Sozzani, S.; Mantovani, A.; Wuyts, A.; De Clercq, E.; Schols, D.; Van Damme, J. Enhanced anti-HIV-1 activity and altered chemotactic potency of NH2-terminally processed macrophage-derived chemokine (MDC) imply an additional MDC receptor. J. Immunol. 1998, 161, 2672-2675.
-
(1998)
J. Immunol
, vol.161
, pp. 2672-2675
-
-
Struyf, S.1
Proost, P.2
Sozzani, S.3
Mantovani, A.4
Wuyts, A.5
De Clercq, E.6
Schols, D.7
Van Damme, J.8
-
67
-
-
46749157569
-
MDC/CCL22 intrathecal levels in patients with multiple sclerosis
-
Galimberti, D.; Fenoglio, C.; Comi, C.; Scalabrini, D.; De Riz, M.; Leone, M.; Venturelli, E.; Cortini, F.; Piola, M.; Monaco, F.; et al. MDC/CCL22 intrathecal levels in patients with multiple sclerosis. Mult. Scler. 2008, 14, 547-549.
-
(2008)
Mult. Scler
, vol.14
, pp. 547-549
-
-
Galimberti, D.1
Fenoglio, C.2
Comi, C.3
Scalabrini, D.4
De Riz, M.5
Leone, M.6
Venturelli, E.7
Cortini, F.8
Piola, M.9
Monaco, F.10
-
68
-
-
1542395857
-
CSF chemokine levels in relapsing neuromyelitis optica and multiple sclerosis
-
Narikawa, K.; Misu, T.; Fujihara, K.; Nakashima, I.; Sato, S.; Itoyama, Y. CSF chemokine levels in relapsing neuromyelitis optica and multiple sclerosis. J. Neuroimmunol. 2004, 149, 182-186.
-
(2004)
J. Neuroimmunol
, vol.149
, pp. 182-186
-
-
Narikawa, K.1
Misu, T.2
Fujihara, K.3
Nakashima, I.4
Sato, S.5
Itoyama, Y.6
-
69
-
-
85020003250
-
Elevated Levels of Proinflammatory Cytokines in Cerebrospinal Fluid of Multiple Sclerosis Patients
-
Khaibullin, T.; Ivanova, V.; Martynova, E.; Cherepnev, G.; Khabirov, F.; Granatov, E.; Rizvanov, A.; Khaiboullina, S. Elevated Levels of Proinflammatory Cytokines in Cerebrospinal Fluid of Multiple Sclerosis Patients. Front. Immunol. 2017, 8, 531.
-
(2017)
Front. Immunol
, vol.8
, pp. 531
-
-
Khaibullin, T.1
Ivanova, V.2
Martynova, E.3
Cherepnev, G.4
Khabirov, F.5
Granatov, E.6
Rizvanov, A.7
Khaiboullina, S.8
-
70
-
-
84918796182
-
The cerebrospinal fluid cytokine signature of multiple sclerosis: A homogenous response that does not conform to the Th1/Th2/Th17 convention
-
Burman, J.; Svensson, E.; Fransson, M.; Loskog, A.S.; Zetterberg, H.; Raininko, R.; Svenningsson, A.; Fagius, J.; Mangsbo, S.M. The cerebrospinal fluid cytokine signature of multiple sclerosis: A homogenous response that does not conform to the Th1/Th2/Th17 convention. J. Neuroimmunol. 2014, 277, 153-159.
-
(2014)
J. Neuroimmunol
, vol.277
, pp. 153-159
-
-
Burman, J.1
Svensson, E.2
Fransson, M.3
Loskog, A.S.4
Zetterberg, H.5
Raininko, R.6
Svenningsson, A.7
Fagius, J.8
Mangsbo, S.M.9
-
71
-
-
0033536062
-
CCR5(+) and CXCR3(+) T cells are increased in multiple sclerosis and their ligands MIP-1alpha and IP-10 are expressed in demyelinating brain lesions
-
Balashov, K.E.; Rottman, J.B.; Weiner, H.L.; Hancock, W.W. CCR5(+) and CXCR3(+) T cells are increased in multiple sclerosis and their ligands MIP-1alpha and IP-10 are expressed in demyelinating brain lesions. Proc. Natl. Acad. Sci. USA 1999, 96, 6873-6878.
-
(1999)
Proc. Natl. Acad. Sci. USA
, vol.96
, pp. 6873-6878
-
-
Balashov, K.E.1
Rottman, J.B.2
Weiner, H.L.3
Hancock, W.W.4
-
72
-
-
85006484066
-
An updated histological classification system for multiple sclerosis lesions
-
Kuhlmann, T.; Ludwin, S.; Prat, A.; Antel, J.; Bruck, W.; Lassmann, H. An updated histological classification system for multiple sclerosis lesions. Acta Neuropathol. 2017, 133, 13-24.
-
(2017)
Acta Neuropathol
, vol.133
, pp. 13-24
-
-
Kuhlmann, T.1
Ludwin, S.2
Prat, A.3
Antel, J.4
Bruck, W.5
Lassmann, H.6
-
73
-
-
84920283093
-
Activation status of human microglia is dependent on lesion formation stage and remyelination in multiple sclerosis
-
Peferoen, L.A.; Vogel, D.Y.; Ummenthum, K.; Breur, M.; Heijnen, P.D.; Gerritsen, W.H.; Peferoen-Baert, R.M.; van der Valk, P.; Dijkstra, C.D.; Amor, S. Activation status of human microglia is dependent on lesion formation stage and remyelination in multiple sclerosis. J. Neuropathol. Exp. Neurol. 2015, 74, 48-63.
-
(2015)
J. Neuropathol. Exp. Neurol
, vol.74
, pp. 48-63
-
-
Peferoen, L.A.1
Vogel, D.Y.2
Ummenthum, K.3
Breur, M.4
Heijnen, P.D.5
Gerritsen, W.H.6
Peferoen-Baert, R.M.7
Van Der Valk, P.8
Dijkstra, C.D.9
Amor, S.10
-
74
-
-
84961390008
-
1,25-Dihydroxyvitamin D3 Facilitates M2 Polarization and Upregulates TLR10 Expression on Human Microglial Cells
-
Verma, R.; Kim, J.Y. 1,25-Dihydroxyvitamin D3 Facilitates M2 Polarization and Upregulates TLR10 Expression on Human Microglial Cells. Neuroimmunomodulation 2016, 23, 75-80.
-
(2016)
Neuroimmunomodulation
, vol.23
, pp. 75-80
-
-
Verma, R.1
Kim, J.Y.2
-
75
-
-
0037334295
-
Regulation of chemokine receptor expression in human microglia and astrocytes
-
Flynn, G.; Maru, S.; Loughlin, J.; Romero, I.A.; Male, D. Regulation of chemokine receptor expression in human microglia and astrocytes. J. Neuroimmunol. 2003, 136, 84-93.
-
(2003)
J. Neuroimmunol
, vol.136
, pp. 84-93
-
-
Flynn, G.1
Maru, S.2
Loughlin, J.3
Romero, I.A.4
Male, D.5
-
76
-
-
80054830970
-
Identification of human NK17/NK1 cells
-
Pandya, A.D.; Al-Jaderi, Z.; Hoglund, R.A.; Holmoy, T.; Harbo, H.F.; Norgauer, J.; Maghazachi, A.A. Identification of human NK17/NK1 cells. PLoS ONE 2011, 6, e26780.
-
(2011)
PLoS ONE
, vol.6
-
-
Pandya, A.D.1
Al-Jaderi, Z.2
Hoglund, R.A.3
Holmoy, T.4
Harbo, H.F.5
Norgauer, J.6
Maghazachi, A.A.7
-
77
-
-
84893372551
-
Disease-modifying therapy in multiple sclerosis and chronic inflammatory demyelinating polyradiculoneuropathy: Common and divergent current and future strategies
-
Melzer, N.; Meuth, S.G. Disease-modifying therapy in multiple sclerosis and chronic inflammatory demyelinating polyradiculoneuropathy: Common and divergent current and future strategies. Clin. Exp. Immunol. 2014, 175, 359-372.
-
(2014)
Clin. Exp. Immunol
, vol.175
, pp. 359-372
-
-
Melzer, N.1
Meuth, S.G.2
-
78
-
-
84857887383
-
Immunological and clinical consequences of treating a patient with natalizumab
-
Schwab, N.; Hohn, K.G.; Schneider-Hohendorf, T.; Metz, I.; Stenner, M.P.; Jilek, S.; Du Pasquier, R.A.; Gold, R.; Meuth, S.G.; Ransohoff, R.M.; et al. Immunological and clinical consequences of treating a patient with natalizumab. Mult. Scler. 2012, 18, 335-344.
-
(2012)
Mult. Scler
, vol.18
, pp. 335-344
-
-
Schwab, N.1
Hohn, K.G.2
Schneider-Hohendorf, T.3
Metz, I.4
Stenner, M.P.5
Jilek, S.6
Du Pasquier, R.A.7
Gold, R.8
Meuth, S.G.9
Ransohoff, R.M.10
-
79
-
-
76449087805
-
Natalizumab treatment in multiple sclerosis: Marked decline of chemokines and cytokines in cerebrospinal fluid
-
Mellergard, J.; Edstrom, M.; Vrethem, M.; Ernerudh, J.; Dahle, C. Natalizumab treatment in multiple sclerosis: Marked decline of chemokines and cytokines in cerebrospinal fluid. Mult. Scler. 2010, 16, 208-217.
-
(2010)
Mult. Scler
, vol.16
, pp. 208-217
-
-
Mellergard, J.1
Edstrom, M.2
Vrethem, M.3
Ernerudh, J.4
Dahle, C.5
-
80
-
-
78650516882
-
Clinical study on CXCL13, CCL17, CCL20 and IL-17 as immune cell migration navigators in relapsing-remitting multiple sclerosis patients
-
Kalinowska-Lyszczarz, A.; Szczucinski, A.; Pawlak, M.A.; Losy, J. Clinical study on CXCL13, CCL17, CCL20 and IL-17 as immune cell migration navigators in relapsing-remitting multiple sclerosis patients. J. Neurol. Sci. 2011, 300, 81-85.
-
(2011)
J. Neurol. Sci
, vol.300
, pp. 81-85
-
-
Kalinowska-Lyszczarz, A.1
Szczucinski, A.2
Pawlak, M.A.3
Losy, J.4
-
81
-
-
84919712350
-
Current perspectives on interferon Beta-1b for the treatment of multiple sclerosis
-
Marziniak, M.; Meuth, S. Current perspectives on interferon Beta-1b for the treatment of multiple sclerosis. Adv. Ther. 2014, 31, 915-931.
-
(2014)
Adv. Ther
, vol.31
, pp. 915-931
-
-
Marziniak, M.1
Meuth, S.2
-
82
-
-
79959847463
-
Quantitative differences in the immunomodulatory effects of Rebif and Avonex in IFN-beta 1a treated multiple sclerosis patients
-
Christophi, G.P.; Christophi, J.A.; Gruber, R.C.; Mihai, C.; Mejico, L.J.; Massa, P.T.; Jubelt, B. Quantitative differences in the immunomodulatory effects of Rebif and Avonex in IFN-beta 1a treated multiple sclerosis patients. J. Neurol. Sci. 2011, 307, 41-45.
-
(2011)
J. Neurol. Sci
, vol.307
, pp. 41-45
-
-
Christophi, G.P.1
Christophi, J.A.2
Gruber, R.C.3
Mihai, C.4
Mejico, L.J.5
Massa, P.T.6
Jubelt, B.7
-
83
-
-
0035283409
-
Chemokine receptor expression on T cells in blood and cerebrospinal fluid at relapse and remission of multiple sclerosis: Imbalance of Th1/Th2-associated chemokine signaling
-
Misu, T.; Onodera, H.; Fujihara, K.; Matsushima, K.; Yoshie, O.; Okita, N.; Takase, S.; Itoyama, Y. Chemokine receptor expression on T cells in blood and cerebrospinal fluid at relapse and remission of multiple sclerosis: Imbalance of Th1/Th2-associated chemokine signaling. J. Neuroimmunol. 2001, 114, 207-212.
-
(2001)
J. Neuroimmunol
, vol.114
, pp. 207-212
-
-
Misu, T.1
Onodera, H.2
Fujihara, K.3
Matsushima, K.4
Yoshie, O.5
Okita, N.6
Takase, S.7
Itoyama, Y.8
-
84
-
-
9244249879
-
Expression of TH1/TH2-related chemokine receptors on peripheral T cells and correlation with clinical disease activity in patients with multiple sclerosis
-
Nakajima, H.; Fukuda, K.; Doi, Y.; Sugino, M.; Kimura, F.; Hanafusa, T.; Ikemoto, T.; Shimizu, A. Expression of TH1/TH2-related chemokine receptors on peripheral T cells and correlation with clinical disease activity in patients with multiple sclerosis. Eur. Neurol. 2004, 52, 162-168.
-
(2004)
Eur. Neurol
, vol.52
, pp. 162-168
-
-
Nakajima, H.1
Fukuda, K.2
Doi, Y.3
Sugino, M.4
Kimura, F.5
Hanafusa, T.6
Ikemoto, T.7
Shimizu, A.8
-
85
-
-
1242264279
-
Immunomonitoring measures in relapsing-remitting multiple sclerosis
-
Matsui, M.; Araya, S.I.; Wang, H.Y.; Matsushima, K.; Saida, T. Immunomonitoring measures in relapsing-remitting multiple sclerosis. J. Neuroimmunol. 2004, 148, 192-199.
-
(2004)
J. Neuroimmunol
, vol.148
, pp. 192-199
-
-
Matsui, M.1
Araya, S.I.2
Wang, H.Y.3
Matsushima, K.4
Saida, T.5
-
86
-
-
33745868391
-
Dynamic T-lymphocyte chemokine receptor expression induced by interferon-beta therapy in multiple sclerosis
-
Krakauer, M.; Sorensen, P.S.; Khademi, M.; Olsson, T.; Sellebjerg, F. Dynamic T-lymphocyte chemokine receptor expression induced by interferon-beta therapy in multiple sclerosis. Scand. J. Immunol. 2006, 64, 155-163.
-
(2006)
Scand. J. Immunol
, vol.64
, pp. 155-163
-
-
Krakauer, M.1
Sorensen, P.S.2
Khademi, M.3
Olsson, T.4
Sellebjerg, F.5
-
87
-
-
0347993165
-
Cyclophosphamide modulates CD4+ T cells into a T helper type 2 phenotype and reverses increased IFN-gamma production of CD8+ T cells in secondary progressive multiple sclerosis
-
Karni, A.; Balashov, K.; Hancock, W.W.; Bharanidharan, P.; Abraham, M.; Khoury, S.J.; Weiner, H.L. Cyclophosphamide modulates CD4+ T cells into a T helper type 2 phenotype and reverses increased IFN-gamma production of CD8+ T cells in secondary progressive multiple sclerosis. J. Neuroimmunol. 2004, 146, 189-198.
-
(2004)
J. Neuroimmunol
, vol.146
, pp. 189-198
-
-
Karni, A.1
Balashov, K.2
Hancock, W.W.3
Bharanidharan, P.4
Abraham, M.5
Khoury, S.J.6
Weiner, H.L.7
-
88
-
-
0242523144
-
Immune parameters associated with early treatment effects of high-dose intravenous methylprednisolone in multiple sclerosis
-
Wang, H.Y.; Matsui, M.; Araya, S.; Onai, N.; Matsushima, K.; Saida, T. Immune parameters associated with early treatment effects of high-dose intravenous methylprednisolone in multiple sclerosis. J. Neurol. Sci. 2003, 216, 61-66.
-
(2003)
J. Neurol. Sci
, vol.216
, pp. 61-66
-
-
Wang, H.Y.1
Matsui, M.2
Araya, S.3
Onai, N.4
Matsushima, K.5
Saida, T.6
-
89
-
-
78651252492
-
Expression and functional activity of chemokine receptors in glatiramer acetate-specific T cells isolated from multiple sclerosis patient receiving the drug glatiramer acetate
-
Hoglund, R.A.; Hestvik, A.L.; Holmoy, T.; Maghazachi, A.A. Expression and functional activity of chemokine receptors in glatiramer acetate-specific T cells isolated from multiple sclerosis patient receiving the drug glatiramer acetate. Hum. Immunol. 2011, 72, 124-134.
-
(2011)
Hum. Immunol
, vol.72
, pp. 124-134
-
-
Hoglund, R.A.1
Hestvik, A.L.2
Holmoy, T.3
Maghazachi, A.A.4
-
90
-
-
0035889488
-
Selective CC chemokine receptor expression by central nervous system-infiltrating encephalitogenic T cells during experimental autoimmune encephalomyelitis
-
Fife, B.T.; Paniagua, M.C.; Lukacs, N.W.; Kunkel, S.L.; Karpus, W.J. Selective CC chemokine receptor expression by central nervous system-infiltrating encephalitogenic T cells during experimental autoimmune encephalomyelitis. J. Neurosci. Res. 2001, 66, 705-714.
-
(2001)
J. Neurosci. Res
, vol.66
, pp. 705-714
-
-
Fife, B.T.1
Paniagua, M.C.2
Lukacs, N.W.3
Kunkel, S.L.4
Karpus, W.J.5
-
91
-
-
40949133230
-
IL4 gene delivery to the CNS recruits regulatory T cells and induces clinical recovery in mouse models of multiple sclerosis
-
Butti, E.; Bergami, A.; Recchia, A.; Brambilla, E.; Del Carro, U.; Amadio, S.; Cattalini, A.; Esposito, M.; Stornaiuolo, A.; Comi, G.; et al. IL4 gene delivery to the CNS recruits regulatory T cells and induces clinical recovery in mouse models of multiple sclerosis. Gene Ther. 2008, 15, 504-515.
-
(2008)
Gene Ther
, vol.15
, pp. 504-515
-
-
Butti, E.1
Bergami, A.2
Recchia, A.3
Brambilla, E.4
Del Carro, U.5
Amadio, S.6
Cattalini, A.7
Esposito, M.8
Stornaiuolo, A.9
Comi, G.10
-
92
-
-
83455205820
-
Macrophage-specific chemokines induced via innate immunity by amino acid copolymers and their role in EAE
-
Kovalchin, J.; Krieger, J.; Genova, M.; Kawamoto, N.; Augustyniak, M.; Collins, K.; Bloom, T.; Masci, A.; Hittinger, T.; Dufour, I.; et al. Macrophage-specific chemokines induced via innate immunity by amino acid copolymers and their role in EAE. PLoS ONE 2011, 6, e26274.
-
(2011)
PLoS ONE
, vol.6
-
-
Kovalchin, J.1
Krieger, J.2
Genova, M.3
Kawamoto, N.4
Augustyniak, M.5
Collins, K.6
Bloom, T.7
Masci, A.8
Hittinger, T.9
Dufour, I.10
-
93
-
-
0034176818
-
Reduced chemokine and chemokine receptor expression in spinal cords of TCR BV8S2 transgenic mice protected against experimental autoimmune encephalomyelitis with BV8S2 protein
-
Matejuk, A.; Vandenbark, A.A.; Burrows, G.G.; Bebo, B.F.; Offner, H., Jr. Reduced chemokine and chemokine receptor expression in spinal cords of TCR BV8S2 transgenic mice protected against experimental autoimmune encephalomyelitis with BV8S2 protein. J. Immunol. 2000, 164, 3924-3931.
-
(2000)
J. Immunol
, vol.164
, pp. 3924-3931
-
-
Matejuk, A.1
Vandenbark, A.A.2
Burrows, G.G.3
Bebo, B.F.4
Offner, H.5
-
94
-
-
0034597050
-
Modulation of experimental autoimmune encephalomyelitis: Effect of altered peptide ligand on chemokine and chemokine receptor expression
-
Fischer, F.R.; Santambrogio, L.; Luo, Y.; Berman, M.A.; Hancock, W.W.; Dorf, M.E. Modulation of experimental autoimmune encephalomyelitis: Effect of altered peptide ligand on chemokine and chemokine receptor expression. J. Neuroimmunol. 2000, 110, 195-208.
-
(2000)
J. Neuroimmunol
, vol.110
, pp. 195-208
-
-
Fischer, F.R.1
Santambrogio, L.2
Luo, Y.3
Berman, M.A.4
Hancock, W.W.5
Dorf, M.E.6
-
95
-
-
84924311105
-
Immune modulation by a tolerogenic myelin oligodendrocyte glycoprotein (MOG)10-60 containing fusion protein in the marmoset experimental autoimmune encephalomyelitis model
-
Kap, Y.S.; van Driel, N.; Arends, R.; Rouwendal, G.; Verolin, M.; Blezer, E.; Lycke, N.; ‘t Hart, B.A. Immune modulation by a tolerogenic myelin oligodendrocyte glycoprotein (MOG)10-60 containing fusion protein in the marmoset experimental autoimmune encephalomyelitis model. Clin. Exp. Immunol. 2015, 180, 28-39.
-
(2015)
Clin. Exp. Immunol
, vol.180
, pp. 28-39
-
-
Kap, Y.S.1
Van Driel, N.2
Arends, R.3
Rouwendal, G.4
Verolin, M.5
Blezer, E.6
Lycke, N.7
‘t Hart, B.A.8
-
96
-
-
84920084997
-
IFN-beta inhibits T cells accumulation in the central nervous system by reducing the expression and activity of chemokines in experimental autoimmune encephalomyelitis
-
Cheng, W.; Zhao, Q.; Xi, Y.; Li, C.; Xu, Y.; Wang, L.; Niu, X.; Wang, Z.; Chen, G. IFN-beta inhibits T cells accumulation in the central nervous system by reducing the expression and activity of chemokines in experimental autoimmune encephalomyelitis. Mol. Immunol. 2015, 64, 152-162.
-
(2015)
Mol. Immunol
, vol.64
, pp. 152-162
-
-
Cheng, W.1
Zhao, Q.2
Xi, Y.3
Li, C.4
Xu, Y.5
Wang, L.6
Niu, X.7
Wang, Z.8
Chen, G.9
-
97
-
-
85039852912
-
A T cell-specific deletion of HDAC1 protects against experimental autoimmune encephalomyelitis
-
Goschl, L.; Preglej, T.; Hamminger, P.; Bonelli, M.; Andersen, L.; Boucheron, N.; Gulich, A.F.; Muller, L.; Saferding, V.; Mufazalov, I.A.; et al. A T cell-specific deletion of HDAC1 protects against experimental autoimmune encephalomyelitis. J. Autoimmun. 2017.
-
(2017)
J. Autoimmun
-
-
Goschl, L.1
Preglej, T.2
Hamminger, P.3
Bonelli, M.4
Andersen, L.5
Boucheron, N.6
Gulich, A.F.7
Muller, L.8
Saferding, V.9
Mufazalov, I.A.10
-
98
-
-
79960195666
-
CCR4 contributes to the pathogenesis of experimental autoimmune encephalomyelitis by regulating inflammatory macrophage function
-
Forde, E.A.; Dogan, R.N.; Karpus, W.J. CCR4 contributes to the pathogenesis of experimental autoimmune encephalomyelitis by regulating inflammatory macrophage function. J. Neuroimmunol. 2011, 236, 17-26.
-
(2011)
J. Neuroimmunol
, vol.236
, pp. 17-26
-
-
Forde, E.A.1
Dogan, R.N.2
Karpus, W.J.3
-
99
-
-
84875804013
-
The importance of CCR4 and CCR6 in experimental autoimmune encephalomyelitis
-
Moriguchi, K.; Miyamoto, K.; Tanaka, N.; Yoshie, O.; Kusunoki, S. The importance of CCR4 and CCR6 in experimental autoimmune encephalomyelitis. J. Neuroimmunol. 2013, 257, 53-58.
-
(2013)
J. Neuroimmunol
, vol.257
, pp. 53-58
-
-
Moriguchi, K.1
Miyamoto, K.2
Tanaka, N.3
Yoshie, O.4
Kusunoki, S.5
-
100
-
-
85021438019
-
Chemokine CCL17 is expressed by dendritic cells in the CNS during experimental autoimmune encephalomyelitis and promotes pathogenesis of disease
-
Ruland, C.; Renken, H.; Kuzmanov, I.; Fattahi Mehr, A.; Schwarte, K.; Cerina, M.; Herrmann, A.; Otte, D.M.; Zimmer, A.; Schwab, N.; et al. Chemokine CCL17 is expressed by dendritic cells in the CNS during experimental autoimmune encephalomyelitis and promotes pathogenesis of disease. Brain Behav. Immun. 2017, 66, 382-393.
-
(2017)
Brain Behav. Immun
, vol.66
, pp. 382-393
-
-
Ruland, C.1
Renken, H.2
Kuzmanov, I.3
Fattahi Mehr, A.4
Schwarte, K.5
Cerina, M.6
Herrmann, A.7
Otte, D.M.8
Zimmer, A.9
Schwab, N.10
-
101
-
-
79251580358
-
CCL22 regulates experimental autoimmune encephalomyelitis by controlling inflammatory macrophage accumulation and effector function
-
Dogan, R.N.; Long, N.; Forde, E.; Dennis, K.; Kohm, A.P.; Miller, S.D.; Karpus, W.J. CCL22 regulates experimental autoimmune encephalomyelitis by controlling inflammatory macrophage accumulation and effector function. J. Leukoc. Biol. 2011, 89, 93-104.
-
(2011)
J. Leukoc. Biol
, vol.89
, pp. 93-104
-
-
Dogan, R.N.1
Long, N.2
Forde, E.3
Dennis, K.4
Kohm, A.P.5
Miller, S.D.6
Karpus, W.J.7
-
102
-
-
84899065548
-
Recent progress in the development of antagonists to the chemokine receptors CCR3 and CCR4
-
Pease, J.E.; Horuk, R. Recent progress in the development of antagonists to the chemokine receptors CCR3 and CCR4. Expert Opin. Drug Discov. 2014, 9, 467-483.
-
(2014)
Expert Opin. Drug Discov
, vol.9
, pp. 467-483
-
-
Pease, J.E.1
Horuk, R.2
-
103
-
-
84942363815
-
Targeting chemokine receptors in disease-A case study of CCR4
-
Solari, R.; Pease, J.E. Targeting chemokine receptors in disease-A case study of CCR4. Eur. J. Pharmacol. 2015, 763, 169-177.
-
(2015)
Eur. J. Pharmacol
, vol.763
, pp. 169-177
-
-
Solari, R.1
Pease, J.E.2
-
104
-
-
1642554783
-
Dominance of CCL22 over CCL17 in induction of chemokine receptor CCR4 desensitization and internalization on human Th2 cells
-
Mariani, M.; Lang, R.; Binda, E.; Panina-Bordignon, P.; D’Ambrosio, D. Dominance of CCL22 over CCL17 in induction of chemokine receptor CCR4 desensitization and internalization on human Th2 cells. Eur. J. Immunol. 2004, 34, 231-240.
-
(2004)
Eur. J. Immunol
, vol.34
, pp. 231-240
-
-
Mariani, M.1
Lang, R.2
Binda, E.3
Panina-Bordignon, P.4
D’Ambrosio, D.5
-
105
-
-
84880582202
-
Safety, tolerability, pharmacokinetics and pharmacodynamics of GSK2239633, a CC-chemokine receptor 4 antagonist, in healthy male subjects: Results from an open-label and from a randomised study
-
Cahn, A.; Hodgson, S.; Wilson, R.; Robertson, J.; Watson, J.; Beerahee, M.; Hughes, S.C.; Young, G.; Graves, R.; Hall, D.; et al. Safety, tolerability, pharmacokinetics and pharmacodynamics of GSK2239633, a CC-chemokine receptor 4 antagonist, in healthy male subjects: Results from an open-label and from a randomised study. BMC Pharmacol. Toxicol. 2013, 14, 14.
-
(2013)
BMC Pharmacol. Toxicol
, vol.14
, pp. 14
-
-
Cahn, A.1
Hodgson, S.2
Wilson, R.3
Robertson, J.4
Watson, J.5
Beerahee, M.6
Hughes, S.C.7
Young, G.8
Graves, R.9
Hall, D.10
-
106
-
-
33746609254
-
Antagonists of CCR4 as immunomodulatory agents
-
Purandare, A.V.; Somerville, J.E. Antagonists of CCR4 as immunomodulatory agents. Curr. Top. Med. Chem. 2006, 6, 1335-1344.
-
(2006)
Curr. Top. Med. Chem
, vol.6
, pp. 1335-1344
-
-
Purandare, A.V.1
Somerville, J.E.2
-
107
-
-
27744568988
-
Optimization of CCR4 antagonists: Side-chain exploration
-
Purandare, A.V.; Wan, H.; Gao, A.; Somerville, J.; Burke, C.; Vaccaro, W.; Yang, X.; McIntyre, K.W.; Poss, M.A. Optimization of CCR4 antagonists: Side-chain exploration. Bioorganic Med. Chem. Lett. 2006, 16, 204-207.
-
(2006)
Bioorganic Med. Chem. Lett
, vol.16
, pp. 204-207
-
-
Purandare, A.V.1
Wan, H.2
Gao, A.3
Somerville, J.4
Burke, C.5
Vaccaro, W.6
Yang, X.7
McIntyre, K.W.8
Poss, M.A.9
-
108
-
-
40849124250
-
An intracellular allosteric site for a specific class of antagonists of the CC chemokine G protein-coupled receptors CCR4 and CCR5
-
Andrews, G.; Jones, C.; Wreggett, K.A. An intracellular allosteric site for a specific class of antagonists of the CC chemokine G protein-coupled receptors CCR4 and CCR5. Mol. Pharmacol. 2008, 73, 855-867.
-
(2008)
Mol. Pharmacol
, vol.73
, pp. 855-867
-
-
Andrews, G.1
Jones, C.2
Wreggett, K.A.3
-
109
-
-
84894823040
-
Internalization of the chemokine receptor CCR4 can be evoked by orthosteric and allosteric receptor antagonists
-
Ajram, L.; Begg, M.; Slack, R.; Cryan, J.; Hall, D.; Hodgson, S.; Ford, A.; Barnes, A.; Swieboda, D.; Mousnier, A.; et al. Internalization of the chemokine receptor CCR4 can be evoked by orthosteric and allosteric receptor antagonists. Eur. J. Pharmacol. 2014, 729, 75-85.
-
(2014)
Eur. J. Pharmacol
, vol.729
, pp. 75-85
-
-
Ajram, L.1
Begg, M.2
Slack, R.3
Cryan, J.4
Hall, D.5
Hodgson, S.6
Ford, A.7
Barnes, A.8
Swieboda, D.9
Mousnier, A.10
-
110
-
-
85029667710
-
Opportunities for therapeutic antibodies directed at G-protein-coupled receptors
-
Hutchings, C.J.; Koglin, M.; Olson, W.C.; Marshall, F.H. Opportunities for therapeutic antibodies directed at G-protein-coupled receptors. Nat. Rev. Drug Discov. 2017, 16, 787-810.
-
(2017)
Nat. Rev. Drug Discov
, vol.16
, pp. 787-810
-
-
Hutchings, C.J.1
Koglin, M.2
Olson, W.C.3
Marshall, F.H.4
-
111
-
-
85000625399
-
Mogamulizumab for the treatment of cutaneous T-cell lymphoma: Recent advances and clinical potential
-
Duvic, M.; Evans, M.; Wang, C. Mogamulizumab for the treatment of cutaneous T-cell lymphoma: Recent advances and clinical potential. Ther. Adv. Hematol. 2016, 7, 171-174.
-
(2016)
Ther. Adv. Hematol
, vol.7
, pp. 171-174
-
-
Duvic, M.1
Evans, M.2
Wang, C.3
-
112
-
-
77649123143
-
Defucosylated humanized anti-CCR4 monoclonal antibody KW-0761 as a novel immunotherapeutic agent for adult T-cell leukemia/lymphoma
-
Ishii, T.; Ishida, T.; Utsunomiya, A.; Inagaki, A.; Yano, H.; Komatsu, H.; Iida, S.; Imada, K.; Uchiyama, T.; Akinaga, S.; et al. Defucosylated humanized anti-CCR4 monoclonal antibody KW-0761 as a novel immunotherapeutic agent for adult T-cell leukemia/lymphoma. Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res. 2010, 16, 1520-1531.
-
(2010)
Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res
, vol.16
, pp. 1520-1531
-
-
Ishii, T.1
Ishida, T.2
Utsunomiya, A.3
Inagaki, A.4
Yano, H.5
Komatsu, H.6
Iida, S.7
Imada, K.8
Uchiyama, T.9
Akinaga, S.10
-
113
-
-
85028912573
-
Mogamulizumab for the treatment of relapsed or refractory adult T-cell leukemia-lymphoma
-
Winsett, F.T.; Lewis, D.J.; Duvic, M. Mogamulizumab for the treatment of relapsed or refractory adult T-cell leukemia-lymphoma. Expert Rev. Hematol. 2017, 10, 757-760.
-
(2017)
Expert Rev. Hematol
, vol.10
, pp. 757-760
-
-
Winsett, F.T.1
Lewis, D.J.2
Duvic, M.3
-
114
-
-
84943329278
-
A strategy to discover decoy chemokine ligands with an anti-inflammatory activity
-
Abboud, D.; Daubeuf, F.; Do, Q.T.; Utard, V.; Villa, P.; Haiech, J.; Bonnet, D.; Hibert, M.; Bernard, P.; Galzi, J.L.; et al. A strategy to discover decoy chemokine ligands with an anti-inflammatory activity. Sci. Rep. 2015, 5, 14746.
-
(2015)
Sci. Rep
, vol.5
, pp. 14746
-
-
Abboud, D.1
Daubeuf, F.2
Do, Q.T.3
Utard, V.4
Villa, P.5
Haiech, J.6
Bonnet, D.7
Hibert, M.8
Bernard, P.9
Galzi, J.L.10
-
115
-
-
84959358996
-
C-C chemokine receptor type 4 antagonist Compound 22 ameliorates experimental autoimmune encephalomyelitis
-
Moriguchi, K.; Miyamoto, K.; Tanaka, N.; Ueno, R.; Nakayama, T.; Yoshie, O.; Kusunoki, S. C-C chemokine receptor type 4 antagonist Compound 22 ameliorates experimental autoimmune encephalomyelitis. J. Neuroimmunol. 2016, 291, 54-58.
-
(2016)
J. Neuroimmunol
, vol.291
, pp. 54-58
-
-
Moriguchi, K.1
Miyamoto, K.2
Tanaka, N.3
Ueno, R.4
Nakayama, T.5
Yoshie, O.6
Kusunoki, S.7
-
116
-
-
84866277908
-
Effect of CC chemokine receptor 4 antagonism on the evolution of experimental autoimmune encephalomyelitis
-
author reply E2414
-
Othy, S.; Topcu, S.; Kaveri, S.V.; Bayry, J. Effect of CC chemokine receptor 4 antagonism on the evolution of experimental autoimmune encephalomyelitis. Proc. Natl. Acad. Sci. USA 2012, 109, E2412-E2413, author reply E2414.
-
(2012)
Proc. Natl. Acad. Sci. USA
, vol.109
, pp. E2412-E2413
-
-
Othy, S.1
Topcu, S.2
Kaveri, S.V.3
Bayry, J.4
-
117
-
-
33846303121
-
Effect of synthetic matrix metalloproteinase inhibitors on lipopolysaccharide-induced blood-brain barrier opening in rodents: Differences in response based on strains and solvents
-
Rosenberg, G.A.; Estrada, E.Y.; Mobashery, S. Effect of synthetic matrix metalloproteinase inhibitors on lipopolysaccharide-induced blood-brain barrier opening in rodents: Differences in response based on strains and solvents. Brain Res. 2007, 1133, 186-192.
-
(2007)
Brain Res
, vol.1133
, pp. 186-192
-
-
Rosenberg, G.A.1
Estrada, E.Y.2
Mobashery, S.3
|